Compound Profiling und Screening
In order to develop therapies for fighting infections caused by new pathogens or resistant microorganisms not only we need new drugs but, more importantly, we need to identify new targets for these drugs to act on.
Ursula Bilitewski studied chemistry at the University of Münster, earning her Ph.D. at the Institute of Physical Chemistry. After spending another year at Münster as a post-doc, she moved to Braunschweig in 1988, where she became part of the HZI – which at that time was called the GBF.
In 1994, she habilitated in biochemistry at the Technische Universität Braunschweig and, since 2002, is an adjunct professor for biochemistry. Her initial research focus, which was on establishing microscale bioanalytical systems, has since shifted to drug research. Her work concentrates on molecular mechanisms and on identifying potential drug targets.
Since 2016, Bilitewski is head of the „Compound Profiling und Screening (COPS)“ research group.
Bachelor & Master
Are you interested in a bachelor or master thesis? We are looking forward to your request!